1997
DOI: 10.4269/ajtmh.1997.57.25
|View full text |Cite
|
Sign up to set email alerts
|

Failure of Mebendazole in Treatment of Human Hookworm Infections in the Southern Region of Mali

Abstract: Preliminary studies indicated that single-dose (500 mg) mebendazole gave disappointing results in the treat ment of hookworm infections (Necator americanus) in Mali. A placebo-controlled, randomized trial conducted with the participation of 103 infected subjects (background hookworm prevalence > 50%) confirmed that mebendazole (Vermox®) did not reduce parasite burdens significanfly, as assessed through fecal egg counts. In contrast, a group of subjects treated with pyrantel (Combantrin®) experienced a signif… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
121
1
1

Year Published

2004
2004
2022
2022

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 198 publications
(124 citation statements)
references
References 2 publications
1
121
1
1
Order By: Relevance
“…At the same time, there are reports for anti helminthic resistance in Belgium (Geerts and Gryseels, 2001) and in Mali (De Clercq et al, 1997). Hence, the question arises, "is the anti helminthic prophylaxis used in a rational manner?"…”
Section: Discussionmentioning
confidence: 99%
“…At the same time, there are reports for anti helminthic resistance in Belgium (Geerts and Gryseels, 2001) and in Mali (De Clercq et al, 1997). Hence, the question arises, "is the anti helminthic prophylaxis used in a rational manner?"…”
Section: Discussionmentioning
confidence: 99%
“…Since each class of drugs has a specific mechanism of action (Martin, Robertson and Bjorn, 1997), resistance to one drug within each class automatically leads to resistance to all other drugs with the same mechanism of action (Michel, 1985). Anthelmintic resistance is not yet common amongst GI nematodes of humans, but already there are some indications that previously effective anthelmintics are losing efficacy (De Clercq et al 1997 ;Reynoldson et al 1997 ;Albonico et al 2003). Resistance is now a major threat to sheep and goat farming in the Southern hemisphere, with multiple drug-resistant parasites present (Varady et al 1993 ;Mwamachi et al 1995 ;van Wyk, Malan and Randles, 1997 ;Waruiru, Ngotho and Mukiri, 1998).…”
Section: Introductionmentioning
confidence: 99%
“…This latter problem is by far the most important because frequent mass chemotherapy with the currently available anthelmintics has generated an environment favouring selection for resistant parasites. Resistance is now virtually global among GI nematodes of livestock (Waller, 1986 ;Gill & Lacey, 1998 ;Jackson & Coop, 2000), and there are some indications of resistance among GI nematodes of humans (Coles, 1995 ;de Clercq et al 1997 ;Reynoldson et al 1997). Resistance has already developed to the three drug classes in current use (the benzimidazoles, the imidazothiazoles/ tetrahydropyrimidines and the macrocyclic lactones), despite each class having a different mode of action (Coles, 1998 ;Martin & Robertson, 2000).…”
Section: Introductionmentioning
confidence: 99%